Relmada Therapeutics Inc. (RLMD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Relmada Therapeutics Inc.

    NASDAQ: RLMD · Real-Time Price · USD
    1.94
    -0.38 (-16.38%)
    At close: Oct 06, 2025, 2:53 PM

    Relmada Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.86M 4.09M 5.4M 44.44M
    Short-Term Investments
    		 41.05M 92.23M 142.93M 167.47M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 21.98K 43.13K 34.88K 28.29K
    Receivables
    		 n/a n/a 512.43K 86.38K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 45.8M 97.51M 152.87M 223.3M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 21.98K 43.13K 34.88K 28.29K
    Total Assets
    		 45.82M 97.55M 152.91M 223.33M
    Account Payables
    		 4.13M 3.51M 5.26M 11.19M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 1.15M 5.68M n/a n/a
    Total Current Liabilities
    		 10.29M 12.19M 12.47M 15.06M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 4.47K n/a 123.00 75.00
    Total Long-Term Liabilities
    		 4.47K n/a 123.00 75.00
    Total Liabilities
    		 10.3M 12.19M 12.47M 15.06M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 35.52M 85.36M 140.44M 208.26M
    Book Value Per Share
    		 1.18 2.84 4.74 11.87
    Common Stock
    		 30.17K 30.1K 30.1K 27.74K
    Retained Earnings
    		 -640.88M -560.9M -462.11M -305.07M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 35.52M 85.36M 140.44M 208.26M
    Total Investments
    		 41.05M 92.23M 142.93M 167.47M

    Add to Watchlist